The biorelated degradability and clearance of siliceous nanomaterials have been
questioned worldwide, since they are crucial prerequisites for the successful translation in …

Nanostructures of diverse chemical nature are used as biomarkers, therapeutics, catalysts,
and structural reinforcements. The decoration with surfactants has a long history and is …

Conventional administration of drugs is limited by poor water solubility, low permeability,
and mediocre targeting. Safe and effective delivery of drugs and therapeutic agents remains …

This tutorial review provides an outlook on nanomaterials that are currently being used for
theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based …

In the past decade, non-invasive and biocompatible mesoporous silica materials as efficient
drug delivery systems have attracted special attention. Great progress in structure control …

Therapeutic proteins are widely used in clinic for numerous therapies such as cancer
therapy, immune therapy, diabetes management and infectious diseases control. The low …

Recently, silica nanoparticles (SNPs) have drawn widespread attention due to their
applications in many emerging areas because of their tailorable morphology. During the last …

New approaches in pharmaceutical chemistry have resulted in more complex drug
molecules in the quest to achieve higher affinity to their targets. However, these 'highly …

MSNs have attracted increasing interest as drug carriers due to promising in vivo results in
small-animal disease models, especially related to cancer therapy. In most cases small …

Research on mesoporous materials for biomedical purposes has experienced an
outstanding increase during recent years. Since 2001, when MCM‐41 was first proposed as …